Currently out of the existing stock ratings of Vernon Bernardino, 199 are a BUY (93.43%), 14 are a HOLD (6.57%).

Vernon Bernardino

Work Performance Price Targets & Ratings Chart

Analyst Vernon Bernardino, carries an average stock price target met ratio of 40.46% that have a potential upside of 59.46% achieved within 251 days. Previously, Vernon Bernardino worked at HC WAINWRIGHT.

Vernon Bernardino’s has documented 367 price targets and ratings displayed on 44 stocks. The coverage was on Healthcare, Basic Materials sectors.

Most recent stock forecast was given on CRDL, Cardiol Therapeutics at 16-Apr-2025.

Wall Street Analyst Vernon Bernardino

Analyst best performing recommendations are on AEMD (AETHLON MEDICAL).
The best stock recommendation documented was for GOVX (GEOVAX LABS) at 8/12/2024. The price target of $8 was fulfilled within 9 days with a profit of $5.83 (268.66%) receiving and performance score of 298.52.

Average potential price target upside

of $222.9 (47.74%) on CVM (CEL-SCI CORP).
of $32.13 (119.87%) on NVAX (NOVAVAX).
of $16.22 (81.72%) on SAVA (CASSAVA SCIENCES).

CVM CEL-SCI Corp NVAX Novavax RMED RA Medical Systems AIKI Aikido Pharma ARTL Artelo Biosciences AYTU Aytu BioScience DYAI Dyadic International ELDN Eledon Pharmaceuticals CYTK Cytokinetics MCRB Seres Therapeutics GOVX GeoVax Labs ABEO Abeona Therapeutics AVEO AVEO Pharmaceuticals CTXR Citius Pharmaceuticals EDSA Edesa Biotech GALT Galectin Therapeutics GMDA Gamida Cell Ltd NDRA ENDRA Life Sciences NRXP NRX Pharmaceuticals SAVA Cassava Sciences ACER Acer Therapeutics ARDS Aridis Pharmaceuticals CANF Can Fite Biopharma Ltd ADR FNCH Finch Therapeutics Group SENS Senseonics Holdings TFFP Tff Pharmaceuticals AEMD Aethlon Medical NVCN Neovasc EVOK Evoke Pharma CADL Candel Therapeutics CRDL Cardiol Therapeutics EXK Endeavour Silver Corp. HUMA Humacyte ENVB Enveric Biosciences PHIO Phio Pharmaceuticals Corp WINT Windtree Therapeutics EYPT Eyepoint Pharmaceuticals GERN Geron ICPT Intercept Pharmaceuticals MGEN Viridian Therapeutics MUX McEwen Mining RGLD Royal Gold VTVT vTv Therapeutics MBRX Moleculin Biotech

Show more stocks

Analyst name

Rating

Rating initiation date

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Vernon Bernardino (HCWAINWRIGHT)

Buy

Since 13-Jan-2020

$690

$684.85 (13298.06%)

$690

5 years 6 months 8 days ago
(29-Jun-2020)

2/2 (100%)

$218.1 (46.22%)

235

Please subscribe to see the analyst performance score

Show more analysts

Please expand the browser size to see the chart

What Year was the first public recommendation made by Vernon Bernardino?

On 2015